Top

BMC Pregnancy and Childbirth

Published in:

Open Access 01-12-2021 | Research

Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study

Authors: Rima D. Yarlagadda, Jonas Johnson, Åse Vårtun, Kari Flo, Ganesh Acharya

Published in: BMC Pregnancy and Childbirth | Issue 1/2021

Abstract

Background

Physiological adaptation in pregnancy is characterized by remodeling of endocrine, cardiovascular and renal functions leading to fluid retention, volume expansion, altered cardiac loading conditions and hyperdynamic circulation. Natriuretic peptides have been used as biomarkers of cardiovascular function, but their associations with gestational age-related changes in maternal cardiac, endothelial and renal function have not been elucidated. The aim of this study was to establish longitudinal reference values for maternal plasma atrial natriuretic peptide (proANP) and C-type natriuretic peptide (CNP) and investigate their temporal association with cardiovascular and renal function in the second half of pregnancy.

Methods

This study was a prospective longitudinal study of 53 low-risk pregnancies. Women were examined every 3–5 weeks during 22–40 weeks of gestation (252 observations). Fasting maternal blood samples were obtained to measure proANP, CNP, creatinine, cystatin C, uric acid, and fibrinogen levels. Cardiac function and systemic hemodynamics were assessed noninvasively by impedance cardiography (ICG) and vascular endothelial function by flow-mediated vasodilation of brachial artery (FMD).

Results

The plasma proANP (R²adj = 0.79; P = 0.007), CNP (R2adj = 0.54; P = 0.005) decreased between 22 and 40 weeks. The creatinine (R²adj = 0.90; P < 0.001), cystatin C (R²adj = 0.93; P = < 0.001) and uric acid (R²adj = 0.83; P < 0.001) increased significantly, whereas the estimated glomerular filtration rate (R²adj = 0.93; P < 0.001) decreased with gestational age. The FMD did not change significantly but fibrinogen (R²adj = 0.79; P < 0.001) increased with advancing gestation. The maternal systemic vascular resistance index (R²adj = 0.50; P < 0.001) increased, stroke index (R²adj = 0.62; P < 0.001) decreased, whereas the cardiac index (R²adj = 0.62; P = 0.438) and thoracic fluid content (R²adj = 0.72; P = 0.132) did not change significantly with gestation. The proANP was associated with thoracic fluid content (R²adj = 0.74; P < 0.001) and fibrinogen (R²adj = 0.78; P = 0.034) but not with other variables of systemic hemodynamics, endothelial function, or renal function. The CNP was not associated significantly with parameters of cardiovascular or renal function.

Conclusion

Longitudinal reference values for maternal plasma proANP and CNP were established. These natriuretic peptides decreased slightly with advancing gestation, but they did not reflect the temporal physiological changes in maternal systemic hemodynamics, vascular endothelial function and renal function during the second half of pregnancy. The proANP correlated with the thoracic fluid content reflecting volume load in pregnancy.

Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17(11):698–717. https://doi.org/10.1038/s41569-020-0381-0.CrossRefPubMed

Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339(5):321–8. https://doi.org/10.1056/NEJM199807303390507.CrossRefPubMed

Barr CS, Rhodes P, Struthers AD. C-type natriuretic peptide. Peptides. 1996;17(7):1243–51.CrossRef

Scotland RS, Ahluwalia A, Hobbs AJ. C-type natriuretic peptide in vascular physiology and disease. Pharmacol Ther. 2005;1015:85–93.CrossRef

Del Ry S, Cabiati M, Clerico A. Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure. Pharmacol Res. 2013;76:190–8. https://doi.org/10.1016/j.phrs.2013.08.006.CrossRefPubMed

Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature. 1985;314(6008):264–6. https://doi.org/10.1038/314264a0.CrossRefPubMed

Hensen J, Abraham WT, Lesnefsky EJ, Levenson B, Groves BM, Schröder K, et al. Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction. Kidney Int. 1992;41(5):1333–9. https://doi.org/10.1038/ki.1992.197.CrossRefPubMed

Moyes AJ, Khambata RS, Villar I, Bubb KJ, Baliga RS, Lumsden NG, et al. Endothelial C-type natriuretic peptide maintains vascular homeostasis. J Clin Invest. 2014;124(9:4039–51.CrossRef

Katz R, Karliner JS, Resnik R. Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation. 1978;58(3 Pt 1):434–41. https://doi.org/10.1161/01.CIR.58.3.434.CrossRefPubMed

10.

Duvekot JJ, Cheriex EC, Pieters FA, Menheere PP, Peeters LH. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol. 1993;169(6):1382–92. https://doi.org/10.1016/0002-9378(93)90405-8.CrossRefPubMed

11.

Castro LC, Hobel CJ, Gornbein J. Plasma levels of atrial natriuretic peptide in normal and hypertensive pregnancies: a meta-analysis. Am J Obstet Gynecol. 1994;171(6):1642–51. https://doi.org/10.1016/0002-9378(94)90416-2.CrossRefPubMed

12.

Sala C, Campise M, Ambroso G, Motta T, Zanchetti A, Morganti A. Atrial natriuretic peptide and hemodynamic changes during Normal human pregnancy. Hypertension. 1995;25(4):631–6. https://doi.org/10.1161/01.HYP.25.4.631.CrossRefPubMed

13.

Thomsen JK, Fogh-Andersen N, Jaszczak P, Giese J. Atrial natriuretic peptide (ANP) decrease during normal pregnancy as related to hemodynamic changes and volume regulation. Acta Obstet Gynecol Scand. 1993;72(2):103–10. https://doi.org/10.3109/00016349309023421.CrossRefPubMed

14.

Lowe SA, Macdonald GJ, Brown MA. Acute and chronic regulation of atrial natriuretic peptide in human pregnancy: a longitudinal study. J Hypertens. 1992;10(8):821–9.CrossRef

15.

Steegers EA, van Lakwijk HP, Fast JH, Godschalx AW, Jongsma HW, Eskes TK, et al. Atrial natriuretic peptide and atrial size during normal pregnancy. Br J Obstet Gynaecol. 1991;98(2):202–6. https://doi.org/10.1111/j.1471-0528.1991.tb13369.x.CrossRefPubMed

16.

Burlingame JM, Yamasato K, Ahn HJ, Seto T, Tang WHW. B-type natriuretic peptide and echocardiography reflect volume changes during pregnancy. J Perinat Med. 2017;45(5):577–83. https://doi.org/10.1515/jpm-2016-0266.CrossRefPubMedPubMedCentral

17.

Reid RA, Prickett TC, Pullar BE, Darlow BA, Gullam JE, Espiner EA. C-type natriuretic peptide in complicated pregnancy: increased secretion precedes adverse events. J Clin Endocrinol Metab. 2014;99(4):1470–8. https://doi.org/10.1210/jc.2013-3758.CrossRefPubMed

18.

Stepan H, Walther T, Walther D, Faber R. Detection of C-type natriuretic peptide in normal pregnancy. J Perinat Med. 1998;26(1):56–8.PubMed

19.

Liang H, Vårtun Å, Flo K, Widnes C, Acharya G. Maternal cardiac function, uterine artery hemodynamics and natriuretic peptides at 22-24 weeks of gestation and subsequent development of hypertensive disorders of pregnancy. Acta Obstet Gynecol Scand. 2019;98(4):507–14. https://doi.org/10.1111/aogs.13525.CrossRefPubMed

20.

Flo K, Wilsgaard T, Vårtun Å, Acharya G. A longitudinal study of the relationship between maternal cardiac output measured by impedance cardiography and uterine artery blood flow in the second half of pregnancy. BJOG Int J Obstet Gynaecol. 2010;117(7):837–44. https://doi.org/10.1111/j.1471-0528.2010.02548.x.CrossRef

21.

Flo K, Blix ES, Husebekk A, Thommessen A, Uhre AT, Wilsgaard T, et al. A longitudinal study of maternal endothelial function, inflammatory response and uterine artery blood flow during the second half of pregnancy. Acta Obstet Gynecol Scand. 2016;95(2):225–32. https://doi.org/10.1111/aogs.12802.CrossRefPubMed

22.

DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17:863–71.CrossRef

23.

Wang Y, Moss J, Thisted R. Predictors of body surface area. J Clin Anesth. 1992;4(1):4–10. https://doi.org/10.1016/0952-8180(92)90111-D.CrossRefPubMed

24.

Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol. 2005;16(5):1404–12. https://doi.org/10.1681/ASN.2004100854.CrossRefPubMedPubMedCentral

25.

Jonsson AS, Flodin M, Hansson LO, Larsson A. Estimated glomerular filtration rate (eGFRCystC) from serum cystatin C shows strong agreement with iohexol clearance in patients with low GFR. Scand J Clin Lab Invest. 2007;67(8):801–9. https://doi.org/10.1080/00365510701397538.CrossRefPubMed

26.

Grubb A, Nyman U, Björk J, Lindström V, Rippe B, Sterner G, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem. 2005 Aug;51(8):1420–31. https://doi.org/10.1373/clinchem.2005.051557.CrossRefPubMed

27.

Grubb A, Nyman U, Björk J. Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin C and eGFRcreatinine. Scand J Clin Lab Invest. 2012;72(1):73–7. https://doi.org/10.3109/00365513.2011.634023.CrossRefPubMed

28.

Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. International brachial artery reactivity task force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002;39(2):257–65. https://doi.org/10.1016/S0735-1097(01)01746-6.CrossRefPubMed

29.

Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des fibrinogens [rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol. 1957;17(4):237–46. https://doi.org/10.1159/000205234.CrossRefPubMed

30.

Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric Modelling. Appl Stat. 1994;43(3):429–67. https://doi.org/10.2307/2986270.CrossRef

31.

Royston P. Calculation of unconditional and conditional reference intervals for foetal size and growth from longitudinal measurements. Stat Med. 1995;14(13):1417–36. https://doi.org/10.1002/sim.4780141303.CrossRefPubMed

32.

Vårtun Å, Flo K, Wilsgaard T, Acharya G. Maternal functional hemodynamics in the second half of pregnancy: a longitudinal study. PLoS One. 2015;10(8):e0135300. https://doi.org/10.1371/journal.pone.0135300.CrossRefPubMedPubMedCentral

33.

Borghi C, Esposti DD, Immordino V, Cassani A, Boschi S, Bovicelli L, et al. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol. 2000;183(1):140–7. https://doi.org/10.1016/S0002-9378(00)24854-0.CrossRefPubMed

34.

Matsuo A, Nagai-Okatani C, Nishigori M, Kangawa K, Minamino N. Natriuretic peptides in human heart: novel insight into their molecular forms, functions, and diagnostic use. Peptides. 2019;111:3–17. https://doi.org/10.1016/j.peptides.2018.08.006.CrossRefPubMed

35.

Miyoshi T, Hosoda H, Miyazato M, Kangawa K, Yoshimatsu J, Minamino N. Metabolism of atrial and brain natriuretic peptides in the fetoplacental circulation of fetuses with congenital heart diseases. Placenta. 2019;83:26–32. https://doi.org/10.1016/j.placenta.2019.06.382.CrossRefPubMed

36.

Kuessel L, Zeisler H, Himmler G, Kundi M, Montanari E, Binder J, et al. Dynamics of serum C-type natriuretic peptide as predictor for preeclampsia. Pregnancy Hypertens. 2018;14:286–92. https://doi.org/10.1016/j.preghy.2018.01.007.CrossRefPubMed

37.

Špiranec K, Chen W, Werner F, Nikolaev VO, Naruke T, Koch F, et al. Endothelial C-type natriuretic peptide acts on Pericytes to regulate microcirculatory flow and blood pressure. Circulation. 2018;138(5):494–508. https://doi.org/10.1161/CIRCULATIONAHA.117.033383.CrossRefPubMed

38.

Prickett TCR, Spittlehouse JK, Miller AL, Liau Y, Kennedy MA, Cameron VA, et al. Contrasting signals of cardiovascular health among natriuretic peptides in subjects without heart disease. Sci Rep. 2019;9(1):12108. https://doi.org/10.1038/s41598-019-48553-y.CrossRefPubMedPubMedCentral

39.

Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Aznaouridis K, Baou K, Bratsas A, et al. Amino-terminal pro-C-type natriuretic peptide is associated with arterial stiffness, endothelial function and early atherosclerosis. Atherosclerosis. 2010;211(2):649–55. https://doi.org/10.1016/j.atherosclerosis.2010.03.020.CrossRefPubMed

40.

McLaughlin K, Audette MC, Parker JD, Kingdom JC. Mechanisms and clinical significance of endothelial dysfunction in high-risk pregnancies. Can J Cardiol. 2018 Apr;34(4):371–80. https://doi.org/10.1016/j.cjca.2018.01.006.CrossRefPubMed

41.

Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis of the literature. Ann Intern Med. 1993, 118;(12):956–63.

42.

Gondek A, Jagodzińska A, Pietrzak B, Mamcarz A, Cudnoch-Jędrzejewska A. Relevance of the assessment of natriuretic peptide plasma concentrations in hypertensive pregnant women. Biomarkers. 2020;25(6):449–57. https://doi.org/10.1080/1354750X.2020.1795264.CrossRefPubMed

43.

Lowe SA, Zammit VC, Mitar D, Macdonald GJ, Brown MA. Atrial natriuretic peptide and plasma volume in pregnancy-induced hypertension. Am J Hypertens. 1991;4(11):897–903. https://doi.org/10.1093/ajh/4.11.897.CrossRefPubMed

44.

Espiner EA, Prickett TC, Taylor RS, Reid RA, McCowan LM. Effects of pre-eclampsia and fetal growth restriction on C-type natriuretic peptide. BJOG. 2015;122(9):1236–43. https://doi.org/10.1111/1471-0528.13397.CrossRefPubMed

45.

Khalil A, Maiz N, Garcia-Mandujano R, Elkhouli M, Nicolaides KH. Longitudinal changes in maternal corin and mid-regional proatrial natriuretic peptide in women at risk of pre-eclampsia. Ultrasound Obstet Gynecol. 2015;45(2):190–8. https://doi.org/10.1002/uog.14685.CrossRefPubMed

46.

Vatansever D, Vatansever P, Giray B, Ertekin AA, Bilsel S. Do N-terminal pro-C-type natriuretic peptide levels relate to severity of preeclampsia? Int J Hypertens. 2020;2020 May 2:2693534.

47.

Lopes van Balen VA, van Gansewinkel TAG, de Haas S, Spaan JJ, Ghossein-Doha C, van Kuijk SMJ, et al. Maternal kidney function during pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2019;54(3):297–307. https://doi.org/10.1002/uog.20137.CrossRefPubMedPubMedCentral

48.

Wiles K, Bramham K, Seed PT, Nelson-Piercy C, Lightstone L, Chappell LC. Serum Creatinine in pregnancy: a systematic review. Kidney Int Rep. 2018;4(3):408–19. https://doi.org/10.1016/j.ekir.2018.10.015.CrossRefPubMedPubMedCentral

49.

Saxena AR, Ananth Karumanchi S, Fan SL, Horowitz GL, Hollenberg NK, Graves SW, et al. Correlation of cystatin-C with glomerular filtration rate by inulin clearance in pregnancy. Hypertens Pregnancy. 2012;31(1):22–30. https://doi.org/10.3109/10641955.2010.507845.CrossRefPubMed

50.

Smith MC, Moran P, Ward MK, Davison JM. Assessment of glomerular filtration rate during pregnancy using the MDRD formula. BJOG. 2008;115(1):109–12. https://doi.org/10.1111/j.1471-0528.2007.01529.x.CrossRefPubMed

51.

Ahmed SB, Bentley-Lewis R, Hollenberg NK, Graves SW, Seely EW. A comparison of prediction equations for estimating glomerular filtration rate in pregnancy. Hypertens Pregnancy. 2009;28(3):243–55. https://doi.org/10.1080/10641950801986720.CrossRefPubMed

52.

Wattanavaekin K, Kitporntheranunt M, Kreepala C. Cystatin C as a novel predictor of preterm labor in severe preeclampsia. Kidney Res Clin Pract. 2018;37(4):338–46. https://doi.org/10.23876/j.krcp.18.0080.CrossRefPubMedPubMedCentral

53.

Larsson A, Palm M, Hansson LO, Axelsson O. Cystatin C and modification of diet in renal disease (MDRD) estimated glomerular filtration rate differ during normal pregnancy. Acta Obstet Gynecol Scand. 2010;89(7):939–44. https://doi.org/10.3109/00016341003739559.CrossRefPubMed

54.

Northridge DB, Findlay IN, Wilson J, Henderson E, Dargie HJ. Non-invasive determination of cardiac output by Doppler echocardiography and electrical bioimpedance. Br Heart J. 1990;63(2):93–7. https://doi.org/10.1136/hrt.63.2.93.CrossRefPubMedPubMedCentral

55.

Sodolski T, Kutarski A. Impedance cardiography: a valuable method of evaluating haemodynamic parameters. Cardiol J. 2007;14(2):115–26.PubMed

Title: Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study
Authors: Rima D. Yarlagadda
Jonas Johnson
Åse Vårtun
Kari Flo
Ganesh Acharya
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: BMC Pregnancy and Childbirth / Issue 1/2021
Electronic ISSN: 1471-2393
DOI: https://doi.org/10.1186/s12884-021-03824-3

2024 ASCO Annual Meeting

Springer Medicine

Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study

Abstract

Background

Methods

Results

Conclusion

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Prediction of labour onset in women who present with symptoms of preterm labour using cervical length

Maternal depression, adverse childhood experiences, and social support in relation to gestational diabetes risk: results from the Albany Infant and Mother Study (AIMS)

Maternal body mass index and country of birth in relation to the adverse outcomes of large for gestational age and gestational diabetes mellitus in a retrospective cohort of Australian pregnant women

Estimating the causal effect of embryo transfer day on clinical in vitro fertilization outcomes using propensity score matching

Psychosocial stratification of antenatal indicators to guide population-based programs in perinatal depression

Oxytocin use in trial of labor after cesarean and its relationship with risk of uterine rupture in women with one previous cesarean section: a meta-analysis of observational studies